SLC2A1 and neoplasm: The immunofluorescence staining of GLUT1 showed decreased expression in PD‐L1 inhibitor‐treated tumors compared to that in control tumors, indicating that tumor hypoxia was improved after ICB treatment (Fig. 4D,I).